Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Registered Direct Offerings [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Private Placement [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member] June 16, 2021 Registered Direct Offering [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member] Registered Direct Offerings [Member]	Common Stock [Member] Private Placement [Member]	Common Stock [Member] June 16, 2021 Registered Direct Offering [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Registered Direct Offerings [Member]	Additional Paid-in Capital [Member] Private Placement [Member]	Additional Paid-in Capital [Member] June 16, 2021 Registered Direct Offering [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Registered Direct Offerings [Member]	Retained Earnings [Member] Private Placement [Member]	Retained Earnings [Member] June 16, 2021 Registered Direct Offering [Member]	Retained Earnings [Member]	Registered Direct Offerings [Member]	Private Placement [Member]	June 16, 2021 Registered Direct Offering [Member]	Total
Balance (in shares) at Dec. 31, 2020				79,246				19,804,787
Balance at Dec. 31, 2020				$ 792				$ 198,048				$ 110,826,949				$ (108,383,108)				$ 2,642,681
Shares issued to consultant & other (in shares)								2,665
Shares issued to consultant & other								$ 27				(4,075)								(4,048)
Vesting expense												565,082								565,082
Net loss																(3,888,713)				(3,888,713)
Issuance of shares and warrants (in shares)					13,488,098	9,043,766
Issuance of shares and warrants					$ 134,881	$ 90,438			$ 14,877,611	$ 15,974,301							$ 15,012,492	$ 16,064,739
Shares issued pursuant to agreement with former CEO related to accrued interest (in shares)								100,401
Shares issued pursuant to agreement with former CEO related to accrued interest								$ 1,004				142,569								143,573
Exercise of warrants (in shares)								5,247,059
Exercise of warrants								$ 52,471				4,442,799								4,495,270
Shares issued pursuant to convertible debt (in shares)								1,107,544
Shares issued pursuant to convertible debt								$ 11,075				502,936								514,011
Balance (in shares) at Mar. 31, 2021				79,246				48,794,320
Balance at Mar. 31, 2021				$ 792				$ 487,944				147,328,172				(112,271,821)				35,545,087
Balance (in shares) at Dec. 31, 2020				79,246				19,804,787
Balance at Dec. 31, 2020				$ 792				$ 198,048				110,826,949				(108,383,108)				2,642,681
Net loss																				(6,462,645)
Balance (in shares) at Jun. 30, 2021				79,246				65,335,159
Balance at Jun. 30, 2021				$ 792				$ 653,352				167,279,695				(114,845,753)				53,088,086
Balance (in shares) at Mar. 31, 2021				79,246				48,794,320
Balance at Mar. 31, 2021				$ 792				$ 487,944				147,328,172				(112,271,821)				35,545,087
Shares issued pursuant to equity line (in shares)								572,504
Shares issued pursuant to equity line								$ 5,725				582,865								588,590
Shares issued to consultant & other (in shares)								47,424
Shares issued to consultant & other								$ 474				48,238								48,802
Vesting expense												33,243								33,243
Net loss																(2,573,932)				(2,573,932)
Issuance of shares and warrants (in shares)							15,520,911
Issuance of shares and warrants							$ 155,209				$ 19,291,087								$ 19,446,296
Shares issued pursuant to transition agreement with former CEO (in shares)								400,000
Shares issued pursuant to transition agreement with former CEO								$ 4,000				(4,000)								0
Balance (in shares) at Jun. 30, 2021				79,246				65,335,159
Balance at Jun. 30, 2021				$ 792				$ 653,352				167,279,695				(114,845,753)				53,088,086
Balance (in shares) at Dec. 31, 2021				79,246				65,614,597
Balance at Dec. 31, 2021				$ 792				$ 656,146				167,649,028				(128,040,282)				40,265,684
Shares issued pursuant to equity line (in shares)								120,000
Shares issued pursuant to equity line								$ 1,200				85,685								86,885
Shares issued to consultant & other (in shares)								171,868
Shares issued to consultant & other								$ 1,719				160,403								162,122
Vesting expense												36,518								36,518
Net loss																(3,370,715)				(3,370,715)
Balance (in shares) at Mar. 31, 2022				79,246				65,906,465
Balance at Mar. 31, 2022				$ 792				$ 659,065				167,931,634				(131,410,997)				37,180,494
Balance (in shares) at Dec. 31, 2021				79,246				65,614,597
Balance at Dec. 31, 2021				$ 792				$ 656,146				167,649,028				(128,040,282)				40,265,684
Net loss																				(13,762,039)
Balance (in shares) at Jun. 30, 2022				79,246				78,155,127
Balance at Jun. 30, 2022				$ 792				$ 781,551				174,555,375				(141,802,321)				33,535,397
Balance (in shares) at Mar. 31, 2022				79,246				65,906,465
Balance at Mar. 31, 2022				$ 792				$ 659,065				167,931,634				(131,410,997)				37,180,494
Shares issued pursuant to equity line (in shares)								195,000
Shares issued pursuant to equity line								$ 1,950				147,174								149,124
Shares issued to consultant & other (in shares)								53,662
Shares issued to consultant & other								$ 536				50,134								50,670
Vesting expense												39,383								39,383
Net loss																(10,391,324)				(10,391,324)
Issuance of shares and warrants (in shares)								12,000,000
Issuance of shares and warrants								$ 120,000				6,387,050								6,507,050
Balance (in shares) at Jun. 30, 2022				79,246				78,155,127
Balance at Jun. 30, 2022				$ 792				$ 781,551				$ 174,555,375				$ (141,802,321)				$ 33,535,397